Study guide

7.4 Inventory, Theft, Loss, and Disposal

Connecticut Multistate Pharmacy Jurisprudence Examination CT MPJE

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the Connecticut MPJE 1.2 Application, Fees, ATT, and Pearson VUE 1.3 Blueprint, Scoring, Retakes, and Study Strategy

2 Connecticut Regulatory Structure

2.1 DCP and the Commission of Pharmacy 2.2 Chapter 400j, 420b/420c, and RCSA 20-576 2.3 Federal vs Connecticut Law (More Restrictive Rule)

3 Pharmacist Licensure, Interns, PIC, and CE

3.1 Pharmacist Qualifications and Exam Path 3.2 Interns, Score Transfer, and Reciprocity 3.3 Pharmacist-in-Charge / Pharmacist Manager 3.4 License Renewal and Continuing Education

4 Technicians and Non-Pharmacist Personnel

4.1 Technician Registration and Certification 4.2 Community Technician Ratios (20-576-36) 4.3 Institutional Ratios and Advanced Pharmacy Technicians 4.4 Technician Limitations, Interns, and Unlicensed Staff

5 Discipline, Impairment, and Unlicensed Practice

5.1 Disciplinary Grounds (CGS § 20-579) 5.2 Impaired Practitioner Reporting and Programs 5.3 Unlicensed Practice, Penalties, and Appeals

6 Federal Drug Law Foundations

6.1 FDCA, Adulteration, and Misbranding 6.2 FDA Approval, Recalls, and OTC vs Rx 6.3 DSCSA, HIPAA, OBRA ’90, and PPPA

7 Federal Controlled Substances

7.1 CSA Schedules and Definitions 7.2 DEA Registration and Forms 222, 106, 41 7.3 Federal Controlled-Substance Prescription Rules 7.4 Inventory, Theft, Loss, and Disposal

8 Prescription Issuance in Connecticut

8.1 Who May Prescribe in Connecticut 8.2 Noncontrolled Prescription Form and Content 8.3 Controlled Prescriptions and the EPCS Mandate

9 Refills, Partial Fills, and Opioid Limits

9.1 Refill Authority (Noncontrolled and CIII–V) 9.2 Partial Fills of Schedule II Prescriptions 9.3 Connecticut Opioid Supply Limits (7-day / 5-day)

10 Administration, CDTM, and Standing Orders

10.1 Pharmacist Immunization Authority 10.2 Collaborative Drug Therapy Management 10.3 Naloxone and Opioid Antagonist Access 10.4 Emergency and Hormonal Contraception

11 Counseling, Confidentiality, and Returns

11.1 Counseling and Offer to Counsel 11.2 HIPAA and Connecticut Confidentiality 11.3 Return, Reuse, and Take-Back

12 Corresponding Responsibility and DUR

12.1 Corresponding Responsibility and Legitimate Medical Purpose 12.2 Prospective Drug Utilization Review 12.3 Exceptions and Conditions Prohibiting Dispensing

13 Transfers, Labeling, Packaging, and Delivery

13.1 Transferring Prescriptions 13.2 Labeling of Dispensed Drugs 13.3 Packaging and the Poison Prevention Packaging Act 13.4 Delivery of Drugs

14 CPMRS, Substitution, and Nonprescription Drugs

14.1 CPMRS Query and Reporting 14.2 Generic and Biosimilar Substitution 14.3 CMEA and Behind-the-Counter Products 14.4 OTC Labeling, Hazardous, and Restricted Nonprescription Drugs

15 Ordering, Records, and Inventories

15.1 Ordering and Acquisition (DEA 222/CSOS) 15.2 Distribution and DSCSA Records 15.3 Recordkeeping Content and Three-Year Retention 15.4 Controlled-Substance Inventories and CT Perpetual CII

16 Storage, Security, and Hazardous Drugs

16.1 Controlled-Substance Storage and Security 16.2 Hazardous Drugs (USP <800>, NIOSH) 16.3 Non-Pharmacist Access to Drugs

17 Compounding and Central Fill

17.1 Nonsterile Compounding (USP <795>, RCSA 20-576-69) 17.2 Sterile Compounding (USP <797>, RCSA 20-576-64) 17.3 Central Fill, 503A, and 503B Outsourcing

18 Pharmacy Permits and Practice Settings

18.1 Pharmacy License, Hours, Manager, and Signage 18.2 Nonresident, Hospital, Nuclear, and Automated Dispensing 18.3 Inspection, Closure, and Facility Discipline

7.4 Inventory, Theft, Loss, and Disposal

Key Takeaways Explain This Topic AI

Federal law requires an initial CS inventory when a registrant first handles controlled substances and a biennial inventory at least every two years thereafter (21 CFR 1304.11). Newly scheduled substances are inventoried on the effective date of scheduling.

Opened containers: exact count or measure for Schedule I/II; estimated count for III–V unless the container holds more than 1,000 tablets or capsules, which then requires an exact count (21 CFR 1304.11(e)(6)).

Federal CS records and inventories must be kept at least two years (21 CFR 1304.04). Connecticut requires three years (CGS § 21a-254(f)–(h)). Keep three years in Connecticut.

Theft or significant loss: DEA Field Division written notice within one business day and Form 106 within 45 days (21 CFR 1301.76(b)). Connecticut CII perpetual-inventory losses are also reported to DCP within 72 hours (CGS § 20-633e(c)).

Pharmacies and institutional pharmacies must maintain a perpetual inventory of each Schedule II controlled substance, reconciled monthly (CGS § 20-633e; PA 18-16). Operational detail is Chapter 15.

Last updated: August 2026

Why the count on the clipboard is a scored statute

Quick Answer: Take an initial inventory the day you first handle CS, then at least every two years ( 21 CFR 1304.11 ). Exact count of open CII ; estimate open CIII–V unless the bottle holds more than 1,000 units. Keep federal records two years ( 1304.04 ); Connecticut three years ( CGS § 21a-254 ). Theft/significant loss: Field Division in one business day , Form 106 in 45 days . Connecticut pharmacies also keep a perpetual CII inventory reconciled monthly ( CGS § 20-633e / PA 18-16 ) — details in Chapter 15 .

NABP 4.2.5 is inventories. Candidates confuse biennial with annual , exact with estimated , two years with three , and Form 106 with Form 41 . This section is the federal engine plus the two Connecticut overlays you were told not to bury: three-year records and perpetual CII . Ordering paperwork, invoice content, and the full perpetual-log workflow are Chapter 15 . Storage and who may hold the safe keys are Chapter 16 .

Federal inventories — initial, biennial, newly scheduled

21 CFR 1304.11(a) requires a complete and accurate record of all controlled substances on hand on the inventory date, in written, typewritten, or printed form at the registered location . “On hand” includes stock the registrant possesses or controls — returns not yet sent, warehouse stock held for the registrant, and employee samples intended for distribution. Take the count at opening or close of business and write which one . Each registered location gets its own inventory.

Initial inventory (1304.11(b)). On the date the person first engages in manufacturing, distributing, or dispensing controlled substances, count everything. If the new pharmacy opens with zero CS on the shelf, record that fact . Zero is an inventory, not an excuse to skip the page.

Biennial inventory (1304.11(c)). After the initial count, take a new inventory of all CS at least every two years . The date may be any date within two years of the previous biennial date. You may inventory on your fiscal year-end; you may not wait two years and a day.

Newly controlled substances (1304.11(d)). When DEA adds a previously unscheduled substance to any schedule, every registrant who possesses it inventories that substance on the effective date of the scheduling rule, then includes it in later biennials. Tramadol’s 2014 placement in Schedule IV is the historical example; the next rescheduling will work the same way.

Opened-container counts for dispensers (1304.11(e)(6)):

Schedule I or II — exact count or measure of the contents.

Schedule III, IV, or V — estimated count or measure, unless the container holds more than 1,000 tablets or capsules , in which case the count must be exact .

An opened 100-count oxycodone bottle is counted tablet by tablet. An opened 100-count alprazolam bottle may be estimated. An opened 1,500-count bottle of a CIII in the back room is counted exactly. Sealed, unopened commercial containers are taken at face value (name, finished form, units per container, number of containers).

Connecticut CGS § 21a-254(h) also requires a complete annual record of all CS stocks, classically within four days of May 1 , with a permitted date shift if the registrant’s general physical inventory is not more than six months from that annual date, kept three years . That annual Connecticut count is stricter than federal biennial . Treat it as a second overlay, and leave the calendar mechanics to Chapter 15 so this section does not become the inventory chapter.

Task Federal rule Connecticut overlay

First day handling CS Initial inventory, including an opening-day zero (1304.11(b)) Same floor; keep the record three years

Recurring complete count At least biennial (1304.11(c)) Annual complete CS inventory ( 21a-254(h) ) plus perpetual CII ( 20-633e )

  • Open CII Exact count Exact, and the perpetual log must stay accurate
  • Open CIII–V Estimate, unless container >1,000 Same count method; three-year retention
  • Newly scheduled drug Inventory on the effective date Include it in CT annual and, if it is CII, in perpetual
  • Record retention — two years versus three

21 CFR 1304.04(a) requires every inventory and other Part 1304 record to be kept at least two years from the date of the inventory or record, available for DEA inspection. Executed order forms and inventories stay at the registered location even if other financial records are centralized. CII inventories and records are maintained separately ; CIII–V may be separate or readily retrievable . Paper CII prescriptions sit in their own file ( 1304.04(h) ).

CGS § 21a-254(f), (g), and (h) require CS records, unit-dose disposition records, and inventories to be kept three years , on the premises, current, and separate from other business records. Perpetual CII records under CGS § 20-633e(d) are also retained not less than three years . Three years wins in Connecticut. Destroying a 222 copy, a biennial, or a Form 106 packet at month 25 because “DEA only wants two years” is a DCP citation waiting for an inspector.

Theft, loss, and what is not a 106

Repeat the 7.2 sequence because inventory chapter items will retest it. 21 CFR 1301.76(b): written notice to the Field Division within one business day of discovery of theft or significant loss , then a complete Form 106 through DEA’s secure network within 45 days . Use the significance factors (quantity, drug, person/process, pattern, diversion attractiveness, local trends). Report whether or not the drugs are recovered.

Connecticut add-on for CII perpetual reconciliation: CGS § 20-633e(c) requires any loss, theft, or unauthorized destruction discovered during the monthly CII reconciliation to be reported to the Commissioner of Consumer Protection not later than 72 hours after discovery ( § 21a-262 and RCSA § 21a-262-3 ). That 72-hour DCP clock is in addition to DEA’s one-business-day notice. It is not a substitute for Form 106, and it is not the same 72 hours as the emergency oral CII covering prescription in 7.3 — do not mash the two clocks together.

Form 41 remains destruction , not theft. A witnessed spill with nothing recoverable is documented on Form 41 (DEA’s pharmacist-manual position) rather than as a 106 diversion event. Expired stock going to a reverse distributor is a 222 (CII) or invoice (III–V) plus the reverse distributor’s Form 41, as 7.2 taught.

Perpetual Schedule II inventory — one paragraph (Chapter 15 for the rest)

Public Act 18-16, § 5 , codified at CGS § 20-633e , requires each pharmacy and institutional pharmacy to maintain a perpetual inventory of each Schedule II controlled substance designated under § 21a-243 . Reconcile that perpetual log monthly . Keep the records on the premises, separate from other records, filed by date, three years , and immediately available to DCP. Losses found at reconciliation go to the Commissioner within 72 hours . This is stricter than federal biennial counting. It does not replace the federal initial/biennial inventory, and it does not apply to CIII–V. Gabapentin is not CII and does not belong on the perpetual CII log (section 7.1). How to structure the log, who initials it, and how it maps to 222 receipts is Chapter 15 .

Scenario: May count, missing bottle, expired tray

A Norwalk pharmacy takes its federal biennial on a Monday close-of-business: every open CII bottle is hand-counted ; CIII–V bottles under 1,000 are estimated; a 1,200-count CIII bulk bottle is counted exactly. The perpetual CII log is reconciled the same week and is short one sealed oxycodone 20 mg 100-count. That is a significant loss : Field Division written notice by the next business day , Form 106 inside 45 days , and DCP within 72 hours . Expired fentanyl lozenges found during the same count are not entered on the 106; they go to a reverse distributor on a 222 the reverse distributor issues . The biennial packet, the perpetual pages, the 106, and the reverse-distributor 222 copy all stay on site three years , not two.

CT may be stricter; more-restrictive wins.

Official anchors

21 CFR 1304.11 — initial, biennial, exact/estimated counts.

21 CFR 1304.04 — two-year federal retention; CII file separation.

21 CFR 1301.76(b) — theft/loss; Form 106.

CGS § 21a-254 — three-year CS records; annual inventory.

CGS § 20-633e / DCP Perpetual Inventory — PA 18-16 CII perpetual, monthly reconciliation, 72-hour DCP report.